New pneumococcal vaccine changes

by | Immunity

From 1 July 2020, there are changes to the National Immunisation Program (NIP) which affect pneumococcal, meningococcal and hepatitis A vaccination.

The changes to pneumococcal immunisation are as follows:

Non-Indigenous Australians

  • The vaccine funded for older non-Indigenous Australians on the National Immunisation Program will be 13vPCV (Prevenar 13), instead of 23vPPV (Pneumovax 23).
  • The age for immunising older Australians has been raised from 65 years and over to 70 years and over.
  • All non-Indigenous adults who don’t have a medically at-risk condition for pneumococcal disease who turn 70 after 1 July 2020 should have one dose of Prevenar 13, even if they have previously had Pneumovax 23.
  • All non-Indigenous adults who are already over 70 on 1 July 2020 are also eligible for a single funded dose of Prevenar 13.

Indigenous Australians

  • For Indigenous Australians, pneumococcal immunisation is NIP funded at age 50 years plus. This encompasses 1 dose of 13vPCV and 2 subsequent doses of 23vPPV.
  • Young Indigenous children in NT, Qld, SA, and WA – in addition to the 4 doses of 13vPCV they already receive, should also now be given 2 NIP-funded doses of 23vPPV pneumococcal vaccine.

Medically at-risk groups

People with certain medical risks/conditions are now eligible for NIP-funded pneumococcal vaccine – one dose of 13vPCV at diagnosis and 2 doses of 23vPPV later. These conditions are:

  • Functional or anatomical asplenia
  • Pneumococcal at risk medical conditions (Some are NIP-funded – the list has been revised and simplified to a new single list of conditions – See Table 1 of the Clinical decision tree for vaccination providers for the Updated list of conditions with eligibility for funding).

This table summarises the changes

Pneumococcal vaccines: summary of changes 1 July 2020
Vaccine Non-indigenous older adults Medically at risk Aboriginal and Torres Strait Islander people
Prevenar 13 (13vPCV)
  • Vaccinate at 70 years, not 65 years
  • Use Prevenar instead of Pneumovax
  • Give Prevenar at 70 years, even if had Pneumovax previously
  • Already over 70 – eligible for funded dose of Prevenar
  • Age 50 or over: NIP-funded – one dose Prevenar + 2 subsequent doses Pneumovax
  • Young indigenous children (NT, Qld, SA and WA): add on 2 NIP-funded doses of Pneumovax to the 4-dose Prevenar schedule they already receive
Pneumovax (23vPPV) No longer recommended

myDr.com.au has a lot more information for your patients on immunisation – on childhood immunisations, on immunisation for older Australians, and on all the individual vaccine-preventable diseases, such as pneumococcal disease.

More information for Health Professionals

NSW Immunisation Schedule changes – 1 July 2020 – Health professional FAQs

Clinical update: National Immunisation Program (NIP) changes form 1 July 2020 – advice for immunisation providers: https://www.health.gov.au/news/clinical-update-national-immunisation-program-nip-schedule-changes-from-1-july-2020-advice-for-vaccination-providers

National Immunisation Program Schedule: https://www.health.gov.au/health-topics/immunisation/immunisation-throughout-life/national-immunisation-program-schedule




Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Signup to our newsletter
Get all the latest health and lifestyle news straight to your inbox
ErrorHere